Axogen, Inc. Files Q1 2025 10-Q

Ticker: AXGN · Form: 10-Q · Filed: May 8, 2025 · CIK: 805928

Axogen, Inc. 10-Q Filing Summary
FieldDetail
CompanyAxogen, Inc. (AXGN)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, medical-devices

TL;DR

Axogen's Q1 2025 10-Q is in. Check financials for latest performance.

AI Summary

Axogen, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the electromedical and electrotherapeutic apparatus sector.

Why It Matters

This filing provides investors and stakeholders with the latest financial and operational data for Axogen, Inc., crucial for understanding the company's current performance and future outlook.

Risk Assessment

Risk Level: medium — The filing is a standard quarterly report, but the company operates in the medical device sector which carries inherent regulatory and market risks.

Key Numbers

  • 2025-03-31 — Period End Date (Indicates the end of the reporting quarter.)
  • 2025-01-01 — Period Start Date (Indicates the start of the reporting quarter.)
  • 2024-12-31 — Previous Year End Date (Provides a point of comparison to the prior fiscal year end.)

Key Players & Entities

  • Axogen, Inc. (company) — Filer of the 10-Q
  • 0000805928-25-000064 (other) — Accession Number for the filing
  • 20250331 (date) — Conformed Period of Report
  • 20250508 (date) — Filed As Of Date
  • 3845 (other) — Standard Industrial Classification Code

FAQ

What is Axogen, Inc.'s Standard Industrial Classification (SIC) code?

Axogen, Inc.'s SIC code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

What is the accession number for this 10-Q filing?

The accession number for this 10-Q filing is 0000805928-25-000064.

What is the conformed period of report for this filing?

The conformed period of report for this filing is March 31, 2025.

When was this 10-Q filing submitted?

This 10-Q filing was submitted on May 8, 2025.

What is Axogen, Inc.'s business address?

Axogen, Inc.'s business address is 13631 Progress Blvd., Suite 400, Alachua, FL 32615.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Axogen, Inc. (AXGN).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.